Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pliakas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 30, 2014
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretionNeil Warner, Aaron Burberry, Maria Pliakas, et al.
Hospital Pediatrics|August 26, 2024
Optimizing Pediatric Rapid Response Teams: Stakeholder Focus GroupsKayla B Phelps, Maria Pliakas, Anisha K Coughlin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 4, 2014
Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinomaSilvana Papagerakis, Emily Bellile, Lisa A Peterson, et al.
Mededpublish (2016)|December 13, 2023
A Student-Led National Conference on Leadership: Broadening the Medical Student RoleChristopher Thomas, Shilpa Mokshagundam, Julia Pitkin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 30, 2014
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretionNeil Warner, Aaron Burberry, Maria Pliakas, et al.
Hospital Pediatrics|August 26, 2024
Optimizing Pediatric Rapid Response Teams: Stakeholder Focus GroupsKayla B Phelps, Maria Pliakas, Anisha K Coughlin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 4, 2014
Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinomaSilvana Papagerakis, Emily Bellile, Lisa A Peterson, et al.
Mededpublish (2016)|December 13, 2023
A Student-Led National Conference on Leadership: Broadening the Medical Student RoleChristopher Thomas, Shilpa Mokshagundam, Julia Pitkin, et al.
Pageof 1